A 67-year-old patient with somnolence and severe hyponatraemia;Vigilanzminderung und ausgeprägte hyponatriämie bei einer 67-jährigen patientin

Internist

Volumn 47, Issue 6, 2006, Pages 623-628

  Seiderer, J ^a   Rust, C ^a   Menth, M ^a   Pusl, T ^a   Jung, M C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Citalopram; Hyponatraemia; Inadequate antidiuretic hormone secretion syndrome; Osmolarity; Selective serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; DIURETIC AGENT; FUROSEMIDE; SEROTONIN UPTAKE INHIBITOR; VASOPRESSIN;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTENSIVE CARE UNIT; SODIUM BLOOD LEVEL; SOMNOLENCE; TREATMENT OUTCOME; VASOPRESSIN RELEASE;

AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; HYPONATREMIA; SEROTONIN UPTAKE INHIBITORS;

EID: 33745123381     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-006-1612-0     Document Type: Article

References (14)

1. Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342: 1581-1589
2. Auernhammer C, Engelhardt D, Göke B, Parhofer K (2003) Praxisbuch Endokrinologie und Stoffwechsel, 1. Aufl. Urban und Fischer, München Jena
3. Barclay TS, Lee AJ (2002) Citalopram-induced SI-ADH. Annals of Pharmacotherapy 36: 1558-1563
4. Degner D, Grohmann R, Kropp S et al. (2004) Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry [Suppl 1]: 39-45
5. Holland S, Townley S, Summerfield R (2003) Citalopram - a risk factor for postoperative hyponatraemia. Anaesthesia 58: 480-501
6. Jorgensen H, Riis M, Knigge U et al. (2003) Serotonin receptors involved in vasopressin and oxytocin secretion. J Neuroendocrinol 15: 242-249
7. Kirby D, Ames D (2001) Hyponatraemia and serotonin re-uptake inhibitors in elderly patients. Int J Geriatr Psychiatry 16: 484-493
8. Martin RJ (2004) Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes. Neurol Neurosurg Psychiatry 75 [Suppl 3]: 22-28
9. Palmer BF, Gates JR, Lader M (2003) Causes and Management of Hyponatremia. The Annals of Pharmacotherapy 37: 1694-1702
10. Rose BD (2004) Causes of the SIADH. UpToDate®
11. Rosner MH (2004) Severe hyponatraemia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors. Am J Med Sci 327(2): 109-111
12. Thomas A, Verbalis J (1995) Hyponatraemia and the syndrome of inappropriate antidiuretic secretion associated with drug therapy in psychiatric patients. CNS Drugs 4: 357-369
13. Vacher CM, Fretier P, Creminon C et al. (2002) Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei. J Neurosci 22: 1513-1522
14. Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R (1999) Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people. Br J Clin Pharmacol 47: 211-217